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ABSTRACT

Proper development, function and maintenance of the central nervous system (CNS) are
reliant on the intricate relationship between glia and neurons. Glia cells possess a variety of key
functions such as maintaining homeostasis, providing neurons with trophic support and the
uptake and recycling of neuronal debris. Disruptions in glial function have been implicated in
neurological disorders. Despite their obvious importance in the CNS, glia cells remain much less
characterized than their neuronal counterparts. With its wide array of genetic tools and its low
glia-to-neuron ratio, Drosophila melanogaster presents itself as a useful model organism in
studies of glial characterization. Rap/Fzr, an activator of the Anaphase Promoting
Complex/Cyclosome (APC/C), a E3 ubiquitin ligase, is the Drosophila homolog of the
mammalian Cdh1. Previous studies have shown that proper function of the APC/C regulates glial
differentiation in the CNS (Kaplow et al., 2008). Our studies show that targeted pan-glial
expression of Rap/Fzr/Cdh1 results in the reduction of glia number in the CNS of 3rd instar
larvae. Adult Drosophila with reduced number of glia cells exhibit progressive age-dependent
phenotypes such as temperature-sensitive paralysis and vacuolization of the brain, as well as
significant lifespan reduction. Employing glia subtype specific GAL4 drivers, we have identified
astrocyte-like glia as a critical cell type in neuroprotection. Targeted expression of Rap/Fzr to
astrocyte-like glia results in temperature-sensitive paralysis and lifespan reduction. These
neurodegenerative phenotypes suggest a vital role for astrocyte-like glia in neuroprotection.
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Introduction
The interactions between glia cells and neurons are crucial for proper development,
maintenance and function of the central nervous system (CNS). Disruptions in glial function
have been widely implicated in several neurodegenerative diseases. Although glia cells have
been shown to possess critical functions, the mechanisms that regulate their development are
largely unknown. Thus, a more detailed characterization of glia cells would enable a greater
understanding of their role in mediating these disorders, as well as their roles in normal function
of the CNS.

Overview of the glia types in the mammalian central nervous system
Glia cells of the mammalian central nervous system are divided into two groups –
microglia and macroglia. Microglia are a unique class of glia cells, in that they are derived from
hematopoietic precursors and act as the resident macrophages of the mammalian brain. As such,
they are largely responsible for the uptake of neural debris and they are key mediators of immune
responses in the brain (Harry, 2013). Recent studies have implicated microglia in the engulfment
of synapses during development of the visual system. These glia cells mediate the ocular
dominance that is observed in the lateral geniculate nucleus by use of the complement system
(Schafer et al., 2012; Figure 1). The importance of microglia in synaptic development has
inspired the new term “quad-partite synapse” (Schafer et at., 2013).
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Macroglia are comprised of the oligodendrocytes and astrocytes. Oligodendrocytes are of
critical importance to the central nervous system as they are the principle myelinating cells for
neurons. Myelination is crucial for neuronal function as it promotes saltatory conduction of a
signal being transmitted down the axonal process. Axon potentials would dissipate through the
axolemma if not for the myelin sheath, and it would be very difficult for neurons to convey
signals, especially cells of particularly long length. Oligodendrocytes are also critical for
neuronal health. By covering much of the cell, they create a microenvironment in which the
axonal portion does not have much contact with the extracellular space (Figure 2). As such, the
oligodendrocyte is the key link between the nerve process and the extracellular environment
(Bankston, et al. 2013).
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Astrocytes are another major class of macroglia in the mammalian brain. Astrocytes
possess several functions that are critical for neuronal functions. Their processes are located in
close proximity to synapse, creating the “tri-partite” synapse (Figure 3). This positioning allows
astrocytes to uptake neurotransmitters from the synaptic cleft. This ability serves three functions.
First, it prevents an abundance of neurotransmitters from accumulating at the cleft, which can
lead to excitotoxicity. Second, it allows astrocytes to recycle neurotransmitters and convert them
into a molecular form that can be utilized by the neurons again. Third, this allows astrocytes to
supply nearby neurons with chemicals that can be used for energy, such as lactate.
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In addition to being able to uptake chemicals, astrocytes have also been shown to release
chemicals into the synaptic cleft. These chemicals have come to be known as gliotransmitters.
These chemicals include glutamate and D-serine. Astrocytes have been implicated in playing a
role in regulating cognitive functions such as learning and memory, as both of these molecules
can bind and open NMDA receptors, which are critical for long term potentiation (LTP) (Ben
Achour and Pascual, 2012).
Astrocytes are also proximal to blood vessels, allowing them to be a critical component
of the blood brain barrier. These cells’ processes form “end-feet” around blood vessels (Figure
4). This allows for the coupling of the neural circuitry to the circulatory system. This astrocytic
bridge allows the astrocytes to play a key role in mediating the transfer of nutrients from blood
stream to nerve cell. Also, since astrocytes could act as a read-out of neural transmission, they
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can regulate the dilation and contraction of blood vessels, mediating the amount of blood flow to
particular areas of the brain (Wolburg et al., 2012).

Astrocytes in health and disease
Considering their numerous functions in the CNS, it is not surprising that malfunctions in
astrocytes have been implicated in neurodegenerative and neurodevelopmental disorders
(Maragakis and Rothstein, 2006; Molofsky et al., 2012).
Amyotrophic lateral sclerosis (ALS) is a debilitating disease in which the motor neurons
degenerate. As a consequence, voluntary motor control is severely impaired. Mutations in the
superoxide dismutase 1 (SOD1) gene have been heavily implicated in this disease. Recent
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evidence has shown that astrocytes harboring the mutated gene secrete neurotoxic factors that
induce hyperexcitability of nearby neurons, which leads to neuronal cell death (Nagai et al.,
2007; Fritz et al., 2013).
Astrocytes have also been implicated in Alexander’s disease, a neurodegenerative disease
in which Rosenthal fibers are formed near astrocyte end-feet (Messing et al., 2012). Glial
fibrillary acidic protein (GFAP) is an intermediate filament protein that is thought to be specific
to astrocytes, although its function is unknown (Maragakis and Rothstein, 2006). This protein is
implicated in Alexander’s disease, as overexpression of the human wild-type protein in
astrocytes in the mouse, and astrocyte-like glia in the fly, results in pathology of the disease (Eng
et al., 1998; Wang et al., 2011).
GFAP is upregulated in astrocytes during formation of the glial scar, which is formed by
astrocytes in response to neural injury. Although the glial scar prevents toxic substances that are
released from the site of injury to influence surrounding tissue, it also prevents axonal
regeneration. Efforts to promote axonal injury would involve circumventing this astrocytic
blockade.
Astrocytes have also been implicated in neurodevelopmental disorders, such as Rett
Syndrome, which is one of the severe causes of mental retardation (Bahi-Buisson, 2013). One of
the genes implicated in Rett Syndrome is methyl-CpG-binding protein 2 (MeCP2), which has
been shown to regulate gene expression in astrocytes (Yasui et al., 2013). In addition, astrocytes
deficient in MeCP2 have been shown to perturb dendritic arborization (Ballas et al., 2009) and
astrocytes expressing functional MeCP2 have been shown to have the capacity to rescue defects
observed in MeCP2 mutant mice (Lioy et al., 2011).

	
  

10	
  

Taken together, this evidence supports the need to study astrocytes more carefully,
especially in the context of the mutations discussed above.

Drosophila melanogaster as a model organism
Drosophila melanogaster presents itself as an ideal model organism for studying glial
development. While the Drosophila CNS includes a complex population of glia cells, the ratio of
glia to neurons in the fly brain is much smaller than that of mammals. In addition, the Drosophila
life cycle is relatively short, and the fly is particularly amenable to genetic manipulations. For
these reasons, the fruit fly has long been established as a strong model organism in
developmental neurobiology.
In particular, fly geneticists employ the GAL4/UAS system for targeted gene expression.
This is a binary system in which the GAL4 gene, which is exogenous to the fly, is transcribed
downstream of a tissue-specific promoter, thus allowing for the expression of GAL4 in certain
classes of tissues and not others. The gene of interest is located downstream of an upstream
activating sequence (UAS), which is the binding site for the GAL4. In addition, a temperaturesensitive GAL80 can be used to direct expression in a temporally regulated manner, as GAL80
inhibits GAL4 at room temperature, but is permissive at elevated temperatures (Brand and
Perrimon, 1993; Suster et al., 2004; Figure 5).
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Glia cells are divided into three categories in the Drosophila CNS, of which include
surface, cortex and neuropil glia. Surface glia cells form a double cell layer on the brain surface.
Perineurial glia cells constitute the top layer, while subperineurial glia cells constitute the bottom
layer and are a key component of the blood-brain barrier (BBB). Cortex glia cells form an
intricate network that surrounds neuronal cell bodies, providing neurons with trophic support
(Hartenstein, 2011). Neuropil glia cells are located in the neuropil regions of the brain, which are
dense with synaptic connections. Neuropil glia cells are further divided into two subclasses:
astrocyte-like and ensheathing glia. Astrocyte-like glia cells have a similar morphology to
mammalian astrocytes and are responsible for neurotransmitter uptake at the synaptic cleft
(Parker and Auld, 2006). Astrocyte-like glia cell bodies reside on the periphery of the neuropil
region and their processes infiltrate the neuropil. Ensheathing glia cells have been shown to
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possess a phagocytotic function and are involved in the clearing of neuronal debris (Doherty et
al., 2009). Ensheathing glia reside on the periphery of the neuropil region and extend into the
neuropil upon axonal damage (Figure 6 & 7).
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The Anaphase Promoting Complex/Cyclosome
The Anaphase-Promoting Complex/Cyclosome (APC/C), an E3 ubiqutin ligase, is a key
player in the ubiquitin proteosome system (UPS). Proteins poly-ubiquitinated by the APC/C are
eventually degraded by the 26S proteasome (Figure 8). The APC/C has been shown to regulate
important processes such as the mitotic cell cycle (Primorac and Musacchio, 2013) and
neuroblast differentiation (Kaplow et al., 2008). The APC/C is a multi-subunit protein comprised
of about 13 subunits. One critical subunit is the activating subunit, of which there are two types:
Cdc20 and Cdh1. Cdc20 and Cdh1 are responsible for the substrate specificity of the APC/C, as
they are the subunits which bind the substrate. This interaction is possible when a molecule
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contains a D-Box or KEN Box region, the binding sites for APC/C (Pfleger and Kirschner,
2000). Mitotic cell cycle progression is promoted by APC/CCdc20, as it ubiquitinates securin,
allowing for separase to cleave the bound sister chromatids at the metaphase plate (van Leuken
et al., 2008).
Retina aberrant in pattern/Fizzy-related (Rap/Fzr) is the Drosophila homolog to the
mammalian Cdh1 (Figure 9). APC/CRap/Fzr/Cdh1 is crucial for mitotic cell exit. Several substrates
of the APC/CRap/Fzr/Cdh1 have been shown to include positive regulators of the cell cycle such as
mitotic cyclins and negative regulators of Cdk inhibitors (Hu et al., 2011). The APC/CRap/Fzr/Cdh1
has also been shown to promote endoreplication in cells (Zielke et al., 2008).
The role of the Ubiquitin Proteosome System in glial development, and more specifically
the role of the APC/CRap/Fzr/Cdh1, has not been examined in great detail. In the adult human brain,
astrocytes have been implicated as progenitor cells for olfactory bulb-bound neurons in the
subventricular zone (SVZ) (Doetsch et al., 1999). In the developing Drosophila brain, astrocytelike glia have been shown to proliferate (Awasaki et al., 2008). A closer inspection of the roles of
cell cycle regulators like the APC/CRap/Fzr/Cdh1 would thus be critical in our advancement in
knowledge of glial development, especially astrocytes.
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Our previous studies have implicated the (APC/C) in regulating differentiation of
neuroblasts. Ectopic expression of Rap/Fzr, by use of the pan-glial GAL4 driver repo-GAL4,
resulted in a decrease of glia cells in the 3rd instar larval brain. The APC/C was shown to target
Loco, a regulator of G-protein signaling (RGS), which prevented differentiation of neuroblasts
into glia (Kaplow et al., 2008; Figure 10). The consequences of this glia reduction in the adult fly
remain to be determined.

In this study we have assessed the consequences of perturbation of glia cell development
in the adult fly. Our results show that adult flies exhibit several neurodegenerative phenotypes,
such as lifespan reduction, temperature-sensitive paralysis and vacuole formation. In using glia
subtype GAL4 drivers to ectopically express Rap/Fzr, we have identified astrocyte-like glia as a
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critical glial subtype in neuroprotection. Targeted expression of Rap/Fzr to astrocyte-like glia
also results in lifespan reduction and temperature-sensitive paralysis. Interestingly, astrocyte-like
glia cells show no evidence of disruption at the 3rd instar larval stage but are vastly disrupted in
the adult brain. This implicates the ubiquitin-proteosome system in regulating astrocyte-like glia
development in the Drosophila CNS.

Methods
Fly strains
The following GAL4 drivers were used to target ectopic expression in the tissue listed:

The follow UAS constructs were used to ectopically express the protein listed:
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Canton-s was used as a wild-type control. tub-GAL80ts was used for temporal control of GAL4
expression. The recombinant strain NP3233-GAL4, UAS-mcD8::GFP was kindly provided by
the Hartenstein Lab (UCLA).
Lifespan
Flies were collected on the day of eclosion and kept in a temperature-controlled incubator. No
more than 20 flies were kept in a vial, with all vials containing both males and females. Flies
were transferred into fresh vials twice a week to reduce death due to bad fly food. The number of
flies found dead was recorded during each transfer.
For the GAL80 experiments:
Flies were treated as all the others involved in the lifespan assay. On day one of eclosion these
flies were heat-shocked at 37ᴼC for ½ hour to allow for GAL4 activity. Fly death was then
recorded as detailed above.
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Temperature-sensitive paralysis
Bottles were emptied of all adult flies in the morning and collected from in the evening of the
same day. Flies were kept in vials at no more than 20 per vial. Flies were transferred 1-2 times a
week and kept in a temperature-controlled incubator. Males and females were kept in the same
vials.
On the day of the experiment flies were exposed to CO2 and sorted into pre-heated glass vials at
a volume of 10-15 to avoid over-crowding. Flies were given 2-3 hours to recover after exposure
to CO2. Flies were tested at 37°C for paralysis for increments of 4 minutes totaling 12 minutes
(data shown is for 12 minutes). The same fly was not tested at multiple temperatures in one
experiment. Flies were considered paralyzed if they were found immobile at the bottom of the
vial (flies that died during the experiment were discarded from the study).
Note: Different flies were used for the lifespan and temperature-sensitive paralysis experiments.
Immunohistochemistry
Third instar larval brains and adult brains were dissected in PBS and fixed in 4% PFA for 20
minutes. 3 x 15 minute washes in PBST were followed by placing dissected brains in primary
antibody at 4°C overnight. The dissected brains were placed in 3 x 15 minute washes in PBST
the following day, after which they were placed in the secondary antibody for 1.5 hours at roomtemperature shaking. Brains were then placed in 3 x 15 minute washes in PBST followed by
mounting on vectashield.
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The primary antibody used was mouse anti-repo (8D12, DHSB) at a dilution of 1:5. The
secondary antibody used was TRITC anti-mouse (DHSB) at a dilution of 1:100.
Results
Loss of glia cells, induced by the ectopic expression of Rap/Fzr, results in neurodegenerative
phenotypes
To assess the consequences of Rap/Fzr-induced loss of glia cells we performed lifespan
and temperature-sensitive paralysis assays. Reduction in longevity is commonly associated with
neurodegeneration mutants, and temperature-sensitive paralysis is a widely used marker for
neuronal dysfunction (Reenan and Rogina, 2007). In our previous studies, UAS-rap/fzr;repoGAL4 flies exhibited a drastic decrease in glia cells at the 3rd instar larval stage (Kaplow et al.,
2008). Adult UAS-rap/fzr;repo-GAL4 flies also exhibited a significant reduction in longevity
(Figure 11 A & B, p < .0001). This phenotype was specific to pan-glial overexpression of
Rap/Fzr, as the pan-neuronal overexpression did not result in lifespan reduction (Figure 11 B).
Similarly, UAS-rap/fzr;repo-GAL4 flies exhibited an age-dependent paralytic phenotype. This
was not observed in elav-GAL4;UAS-rap/fzr flies (Figure 11 D).
These data indicate that pan-glial ectopic expression of Rap/Fzr may adversely affect the
neuronal population. To assess this, we performed light and electron microscopy. UASrap/fzr;repo-GAL4 fly brains formed vacuoles in the lamina and medulla regions of the optic
lobe (Figure 11 E, black arrows). Similarly, UAS-rap/fzr;repo-GAL4 flies formed vacuoles in the
central brain neuropil regions (Figure 11 F, red arrows). The severity of both phenotypes
worsened as the flies aged, which may be causal to the age-dependent paralysis experienced by
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these flies. Taken together, these data indicate that flies experienced neurodegeneration as a
result of loss of glia cells or perturbation of existing glia by the ectopic expression of Rap/Fzr.
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Glia subtype specificity of GAL4 drivers
Although our results indicate the critical importance of glia cells in the healthy fly brain,
they do not shed light on the glia subtypes responsible for the phenotypes observed. Ectopic
expression of Rap/Fzr in individual types of glia cells would allow for the identification of the
causal glia cells. To this end, we utilized GAL4 drivers specific to different subtypes of glia
cells. We first characterized the expression patterns of these GAL4 drivers in the 3rd instar larval
brain. To accomplish this we crossed each GAL4 driver with the reporter gene UASmcD8::GFP. mcD8::GFP is a membrane-tethered protein that would afford the visualization of
the cell’s morphology. We immunostained with anti-GFP and anti-repo, a glia specific nuclear
antibody. The following criteria were used to characterize the glia cells: repo-positive, GFPpositive and exhibition of previously published morphologies (Haretnstein, 2011; Stork et al.,
2013). Our results showed that several GAL4 lines were specific to their respective subtype,
while others exhibited cross expression in another subtype (Figure 12).
Two lines that exhibited this cross expression were NP1243-GAL4 and NP2222-GAL4.
Though NP1243-GAL4 is published as an astrocyte-like glia driver, it also labeled cortex glia
(Figure 12 E and F). NP2222-GAL4 is published as a cortex glia driver but labeled other
morphologically distinct glia cells (Figure 12 C). These data call into question the use of these
GAL4 drivers in experiments which necessitate the targeted expression of a gene of interest in
one type of glia.
In addition, all of these GAL4 drivers showed cross expression in a subset of neurons
(Awasaki et al., 2008). That said, our lifespan analysis and paralysis results do not indicate that
ectopic expression of Rap/Fzr in neurons causes neurodegenerative phenotypes. Thus, we used
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these GAL4 drivers to assess the effects of Rap/Fzr overexpression in distinct subtypes of glia,
neglecting the simultaneous expression in neurons.

Astrocyte-like glia-specific ectopic expression of Rap/Fzr perturbs development, and results in
neurodegenerative phenotypes.
These GAL4 drivers were crossed into UAS-rap/fzr, and the progeny were tested for
lifespan reduction and temperature-sensitive paralysis. As our results show, ectopic expression
of Rap/Fzr in astrocyte-like glia showed the most severe neurodegenerative phenotypes (Figure
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13 and 14). The phenotypes were much more severe when using NP3233-GAL4 than NP1243GAL4 but as previously stated NP1243-GAL4 is not astrocyte-like glia-specific (Figure 12 E and
F). Targeted expression of Rap/Fzr in astrocyte-like glia cells, driven by the GAL4 driver
NP3233-GAL4, resulted in severe lifespan reduction (Figure 14 A & B) and temperaturesensitive paralysis (Figure 14 C). Interestingly, these phenotypes were more severe than those
observed in UAS-rap/fzr;repo-GAL4 flies, which may be explained by the varying strength of
different GAL4 drivers. Another possibility is that ectopic expression of Rap/Fzr in another
subtype of glia buffered the pan-glial phenotype.
We questioned whether the effects we observed were specific to the APC/CRap/Fzr/Cdh1. To
assess this, we used repo-GAL4 to drive expression of UAS-highwire, another E3 ubiquitin
ligase. We saw no change in lifespan (Figure 13 G) no paralytic phenotype (Figure 13 J). In
addition, we used repo-GAL4 to drive expression of UAS-APC2, which is the catalytic subunit of
the APC/C. We did see a mild reduction in lifespan (Figure 13 H). This phenotype was not
nearly as severe as the ectopic expression of Rap/Fzr, which can be explained by APC2’s
function during all APC/C activity, including while Cdc20 is bound to the APC/C rather than
Cdh1.
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Considering the APC/C’s role in regulating neuroblasts differentiation, we hypothesized
that the astrocyte-like glia-targeted overexpression of Rap/Fzr was resulting in loss of astrocytelike glia cells in the 3rd instar larval brain. To explore this idea we used NP3233-GAL4 to
simultaneously express Rap/Fzr and UAS-mcD8::GFP. Unexpectedly, astrocyte-like glia cells
were not disrupted in the 3rd instar larval brain, as they exhibited wild-type morphology, location
and cell number (Figure 15 A & B). There was an increase in average nucleus size in these glia
cells (Figure 15 C), which could be explained by the APC/C’s role in endoreplication (Zielke et
al., 2008). Interestingly, astrocyte-like glia cells were greatly disrupted in the brains of one-dayold adults (Figure 15 A).
These data indicate that ectopic expression of Rap/Fzr in astrocyte-like glia cells disrupts
their development beyond the 3rd instar larval period. We hypothesized that a delayed expression
of the GAL4 beyond the adult stage would allow for normal development of astrocyte-like glia,
and prevent the neurodegenerative phenotypes. To this end, we employed a temperaturesensitive GAL80 construct. GAL80 inhibits GAL4 at room temperature, but allows GAL4
activity when placed at an elevated temperature (Suster et al., 2004). Tub-GAL80ts;NP3233GAL4/UAS-rap/fzr flies were heat-shocked at 37ᴼC on the day of eclosion, and their longevity
was monitored. These flies did not show a reduction in lifespan (Figure 15 D). These data
indicate that directed ectopic expression of Rap/Fzr in astrocyte-like glia disrupts their
development during the pupal period, thus resulting in lifespan reduction and possibly
temperature-sensitive paralysis.
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Discussion
On the role of APC/CRap/Fzr/Cdh1 in astrocyte-like glia development
There has been an increasing interest in the function of glia cells in the context of both
normal brain function and disease. No other glia cell has garnered more interest than the
astrocyte. Possessing critical functions such as reuptake and recycling of neurotransmitters and
establishing the blood brain barrier, the astrocyte is truly an essential cell of the nervous system.
Indeed, astrocytes have be implicated in several neurodevelopmental and neurodegenerative
disorders. That said, there is much to be learned about the development of astrocytes. Here we
have shown evidence that the Ubiquitin Proteasome System plays a role in developing astrocytelike glia in the Drosophila central nervous system.
The astrocyte-like glia targeted ectopic expression of Rap/Fzr resulted in severe
neurodegenerative phenotypes (lifespan reduction and temperature-sensitive paralysis). This led
to the unexpected result that astrocyte-like glia were still intact in the 3rd instar larval brains.
These results now raise two questions. First, does the APC/CRap/Fzr/Cdh1 regulate differentiation of
ganglion mother cells into astrocyte-like glia? Second, are the glia observed at the 3rd instar
larval stage functional?
On the matter of differentiation, this may be an issue of the onset of the GAL4 driver’s
expression. GAL4 drivers are limited in expression by the activity of the promoter region. The
repo-GAL4 driver is turned on very early in development due to the transcriptional regulatory
function of Repo during gliogenesis. In contrast, the earliest we have observed expression of
NP3233-GAL4 is during the 3rd instar larval stage (this is the earliest we have looked).
Unfortunately, the promoter associated with NP3233-GAL4 is currently unknown. That said, a
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GFP expression profile of NP3233-GAL4, UAS-mcD8::GFP flies throughout development
would give an indication as to the onset of this drivers activity. If NP3233-GAL4 turns on after
the differentiation decision has been made, our results do not rule out the role of the
APC/CRap/Fzr/Cdh1 in regulating the differentiation of these cells.
The lineages of adult astrocyte-like glia are currently unknown. That is, we are not sure if
the cells that populate the adult brain are derived from pre-existing astrocyte-like glia, or if these
are cells that have differentiated from other ganglion mother cells (there is evidence that the
former is the case, as is discussed below). This is clearly a gray area that must be cleared.
Recently developed tools such as photo-convertible fluorescent proteins could lend insight into
this aspect of development. These proteins initially fluoresce at a particular wavelength but
change when exposed to UV light (Hoi et al., 2010). Utilization of this powerful tool could help
us identify the adult astrocyte-like glia that came from previous astrocyte-like glia and the
alternative.
On the issue of functionality, we are currently limited in assessing the functionality of
these cells at this particular stage. Many studies of astrocyte-like glia have centered on their role
in the adult brain, not the larval stages (Awasaki et al., 2008; Ng et al., 2011). Thus, the known
roles for astrocyte-like glia during the 3rd instar period are limited. It is known that astrocyte-like
glia cells are expressing the extracellular amino acid transporter 1 (EAAT1) this early in
development (GFP labeled astrocyte-like glia are observed in the brains of EAAT1-GAL4, UASmcD8::GFP larvae). One approach would be to stain for EAAT1, of which there is an antibody
available. Loss of expression of this protein would clearly indicate malfunction, whereas its
expression would be an indirect indication that these glia cells are retrieving neurotransmitters
from the synaptic cleft.
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Recent work has examined the importance of calcium signaling in astrocyte-like glia
function. Genetically encoded calcium indicators (GECI’s) have recently been developed (Tian
et al., 2012), and there are fly strains in which genes for these GECI’s are downstream of UAS
sequences. In addition, the transparency of larvae lends itself to live imaging. Thus, the tools are
available to study calcium signaling in Drosophila in a tissue specific manner. Assessment of
calcium imaging in these mutant flies could also shed light on the functionality of their astrocytelike glia.
Although astrocyte-like glia exhibited wild-type phenotypes (location, morphology,
number and repo-positive) there was one difference – their nucleus size. Although the
APC/CRap/Fzr/Cdh1 is well characterized for it’s role in stabilizing G0 phase, and preventing entry
into S phase, it has also been shown to promote endoreplication. We have not yet observed any
poly-nucleated astrocyte-like glia in 3rd instar larval brains but it would be interesting to assess
this in later stages of development (we have observed poly-nucleated cortex glia of UASrap/fzr;repo-GAL4 larvae). This question ties into the next topic at hand, that is the apparent
failure of these astrocyte-like glia cells to proliferate during the pupal stage.
We saw an astonishing disruption in the astrocyte-like glia population in one-day-old
adults, compared to their normalcy during the larval stage. There are currently two prevailing
hypotheses about this phenomenon. First, that astrocyte-like glia cells are dying after the 3rd
instar stage and do not make it beyond eclosion. Second, that ectopic expression of Rap/Fzr is
causing a proliferative defect of the glia cells present in 3rd instar larvae.
With respect to the first hypothesis, prevailing evidence suggest that the APC/CRap/Fzr/Cdh1
is involved in promoting cell survival. Modulator of apoptotic protein 1 (MOAP1), a pro-
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apoptotic factor, is a substrate of the APC/CRap/Fzr/Cdh1. APC/CRap/Fzr/Cdh1 is also inhibited by
TRIM39, another E3 ubiquitin ligase that promotes cell death (Huang et al., 2012). In addition,
the APC/CRap/Fzr/Cdh1 has also been implicated in neuronal survival (Almeida, 2012). That said,
these studies were not focused on glial biology specifically. Thus, we cannot rule out the
promotion of cell death in these glia cells. This could be assessed by simply tracking the
progression of the pupal formation while staining for both anti-repo and anti-cleaved caspase 3.
Co-localization of these two antibodies would be direct evidence that glia cells are dying, which
would support the hypothesis.
With respect to the second hypothesis, the APC/CRap/Fzr/Cdh1 is a well-known regulator of
the cell cycle. During G1, the APC/CRap/Fzr/Cdh1 targets Skp2, a component of the SCF ubiquitin
ligase, and Ets2, a transcription factor, for ubiquitination (Wei et al., 2004; Li et al., 2008).
Degradation of Skp2 and Ets2 prevent entry into S phase (Li and Zhang, 2009). Recent studies
have shown that astrocyte-like glia proliferate during the 3rd instar larval and pupal periods.
Thus, ectopic expression of Rap/Fzr may be perturbing this proliferation from occurring. We
have shown evidence that inducing Rap/Fzr expression in the adult brain does not result in
lifespan reduction. This supports the proliferative defect hypothesis, as Rap/Fzr is being induced
after the proliferation occurs and the glia cells have already developed normally. A more direct
approach would be to knock out Skp2 or Ets2 and monitor development of these glia cells. If a
dominant negative of these proteins is available downstream of a UAS, then it’s expression can
be induced prior to 3rd instar stages by use of the NP3233-GAL4 driver. If the hypothesis is
correct, this should lead to the perturbation of astrocyte-like glia in the adult, as well as lifespan
reduction and temperature-sensitive paralysis.
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On the involvement of APC/CRap/Fzr/Cdh1 in neurodegenerative disorders
There is precedent for the involvement of the Ubiquitin Proteosome System in
neurodegenerative diseases. In Parkinson’s, one of the most prominent neurodegenerative
disorders in which death of dopaminergic neurons in the substantia nigra leads to motor deficits,
one of the genes involved is parkin, which encodes for an E3 ubiquitin ligase (Worth, 2013).
The APC/CRap/Fzr/Cdh1 has been implicated in neurodegenerative diseases such as
Alzheimer’s because of it’s regulation of the cell cycle. The APC/CRap/Fzr/Cdh1 is found in postmitotic neurons, as it is involved in synapse formation and axon growth. Malfunction of the
APC/CRap/Fzr/Cdh1 could lead to reentry of post-mitotic neurons into the cell cycle, which would
lead to apoptosis (Aulia and Tang, 2006) In fact, high expression of APC/CRap/Fzr/Cdh1 in neurons
has been shown to be responsible for their ability to maintain an antioxidant status. In contrast,
low expression of APC/CRap/Fzr/Cdh1 in surrounding astrocytes allows their processing of glucose,
enabling them to supply neurons with energy (Herrero-Mendez et al., 2009). Whether or not this
system is occurring in the Drosophila brain remains unknown but we may be causing an
imbalance in this bioenergetic relationship.
There has recently been a model of Alexander’s disease established in the fly (Wang et
al., 2011). Overexpression of the mammalian mutant GFAP gene in fly glia causes seizures and
Rosenthal fiber-like formations within the glia. These phenotypes are ameliorated by the
simultaneous expression of Hsp70. Hsp70 is downstream of heat shock factor 2 (HSF2), which is
a transcription factor. HSF2 is a known target of the APC/CRap/Fzr/Cdh1 (Ahlskog et al., 2010). This
implicates the APC/CRap/Fzr/Cdh1 in development of Alexander’s disease.
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These first three examples examine the consequence of lost APC/CRap/Fzr/Cdh1 function,
while the third implies a gain-of-function phenotype. In our current model, the increased activity
(or untimely activity) of the APC/CRap/Fzr/Cdh1 is responsible for the observed phenotypes.
APC/CRap/Fzr/Cdh1 has commonly been referred to as a tumor suppressor because of it’s halting of
the cell cycle (Jackson, 2004). It seems that the APC/CRap/Fzr/Cdh1’s tumor suppressive function is
inhibiting normal astrocyte-like glia growth. It would be interesting to see if in a loss-of-function
background these astrocyte-like glia actually over-proliferate, causing a cancerous glial
population. This could easily be accomplished by crossing NP3233-GAL4,UAS-mcD8::GFP into
a mutant background for Rap/Fzr and observing the cells’ development and growth in the adult
brain.
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